October 29, 2025 - 02:12

IRVINE, Calif., Oct. 28, 2025 -- Beta Bionics, Inc., a leader in diabetes management solutions, has reported impressive financial results for the third quarter of 2025, which ended on September 30. The company achieved net sales of $27.3 million, marking a remarkable 63% increase from $16.7 million during the same period in 2024. This surge in revenue highlights the growing demand for innovative diabetes management products.
In addition to the strong quarterly performance, Beta Bionics has raised its full-year guidance for the fiscal year ending December 31, 2025. The company attributes this optimistic outlook to its expanding market presence and the successful introduction of new products within the Durable Medical Equipment (DME) channel.
The positive financial results reflect Beta Bionics' commitment to enhancing the quality of life for individuals living with diabetes through cutting-edge technology. As the company continues to innovate, stakeholders are eager to see how these developments will shape the future of diabetes care.
June 15, 2026 - 08:33
Why finance workers need soft skills more in harder timesThe era of the number-crunching financier who rarely speaks is fading fast. As economic uncertainty drags on and market volatility becomes the norm, finance workers are being told that technical...
June 14, 2026 - 21:29
Warsh Caught Between Trump and Bond Market Betting on Rate HikesJust three weeks into his tenure as Federal Reserve Chairman, Kevin Warsh is already confronting a high-stakes challenge. Inflation is roaring back at a faster pace than many economists predicted,...
June 14, 2026 - 12:57
PNC Financial Services Group (PNC) Stock Valuation Check After Strong Recent PerformancePNC Financial Services Group has been on a notable run, drawing investor attention after a strong recent stretch. The stock rose 1.6% over the past day, gained about 4.1% over the past week, and...
June 13, 2026 - 17:19
JPMorgan Chase & Co. (JPM) CEO Marianne Lake Expects 2026 Loan Growth To Exceed The Industry AverageMarianne Lake, the CEO of JPMorgan Chase & Co., told investors this week that she expects the bank`s loan portfolio to grow faster than the industry average by 2026. Speaking at a financial...